These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 19893033)
21. Does the position of the premature termination codon in COL7A1 correlate with the clinical severity in recessive dystrophic epidermolysis bullosa? Ishiko A; Masunaga T; Ota T; Nishikawa T Exp Dermatol; 2004 Apr; 13(4):229-33. PubMed ID: 15086338 [TBL] [Abstract][Full Text] [Related]
22. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo. Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675 [TBL] [Abstract][Full Text] [Related]
23. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922 [TBL] [Abstract][Full Text] [Related]
24. Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa. Atanasova VS; Jiang Q; Prisco M; Gruber C; Piñón Hofbauer J; Chen M; Has C; Bruckner-Tuderman L; McGrath JA; Uitto J; South AP J Invest Dermatol; 2017 Sep; 137(9):1842-1849. PubMed ID: 28549954 [TBL] [Abstract][Full Text] [Related]
33. One Novel Frameshift Mutation on Exon 64 of COL7A1 Gene in an Iranian Individual Suffering Recessive Dystrophic Epidermolysis Bullosa. Khaniani MS; Sohrabi N; Derakhshan NM; Derakhshan SM Ann Clin Lab Sci; 2015; 45(5):582-4. PubMed ID: 26586712 [TBL] [Abstract][Full Text] [Related]
34. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico. Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190 [TBL] [Abstract][Full Text] [Related]
35. Type VII collagen gene mutations (c.8569G>T and c.4879G>A) result in the moderately severe phenotype of recessive dystrophic epidermolysis bullosa in a Korean patient. Cho JW; Nakano H; Lee KS J Korean Med Sci; 2009 Apr; 24(2):256-61. PubMed ID: 19399267 [TBL] [Abstract][Full Text] [Related]
37. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972 [TBL] [Abstract][Full Text] [Related]
38. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa. Woodley DT; Cogan J; Mosallaei D; Yim K; Chen M J Dermatol Sci; 2021 Nov; 104(2):104-111. PubMed ID: 34674926 [TBL] [Abstract][Full Text] [Related]
40. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A. Liu J; Wang L Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]